by TractManager | May 17, 2023 | Emerging Technology Report
Veozah is an NK3 receptor antagonist indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | May 12, 2023 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of male-to-female (MtF) gender-affirming surgery (GAS) for adolescents with gender dysphoria (GD).If you have a Hayes...
by TractManager | May 9, 2023 | Health Technology Assessment
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the effectiveness and safety of transoral incisionless fundoplication (TIF) 2.0 using EsophyX (EndoGastric Solutions Inc.) to treat chronic gastroesophageal reflux disease (GERD)...
by TractManager | May 9, 2023 | Health Technology Assessment
Focus of Report: The focus of this Health Technology Assessment is to evaluate the effectiveness and safety of transoral incisionless fundoplication (TIF) 2.0 when performed concomitantly with laparoscopic hiatal hernia repair (concomitant transoral incisionless...
by TractManager | May 5, 2023 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of facial feminization surgery (FFS)—i.e., multiple procedures in the head and/or neck regions combined in a single...
Recent Comments